Gefitinib: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 May 2024

  • curprev 02:1202:12, 23 May 2024‎ Ai talk contribs‎ 5,644 bytes +5,644‎ Created page with "== Introduction == Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor used in the treatment of certain types of non-small cell lung cancer (NSCLC). It is a small molecule tyrosine kinase inhibitor (TKI) that specifically targets the EGFR tyrosine kinase domain, thereby inhibiting the downstream signaling pathways that promote tumor cell proliferation and survival. Gefitinib is marketed under the trade name Iressa and was the first EGFR TKI to be a..."
Retrieved from "https://canonica.ai/page/Gefitinib"